At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
Barostim Neo Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Baroreflex Activation Therapy in Heart Failure
In Brief
A clinical study evaluating Barostim Neo System for Heart Failure. Completed, enrolled 12 participants across 1 site.
Detailed Summary
The purpose of this clinical investigation is to evaluate the efficacy and safety of the CVRx Barostim Neo System in the treatment of patients with heart failure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesItaly
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2011
First PostedDec 2011
Primary CompletionJul 2013
Study CompletionMar 2015
TodayJul 2026
First PostedDec 2, 2011
Enrollment StartNov 1, 2011
Primary CompletionJul 1, 2013
Study CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 14.6 years ago
Interventions
Barostim Neo Systemdevice
Baroreflex Activation Therapy using the Barostim Neo System